ControlRad Scores $15 Million

Want to share this story?

ControlRad, a med-tech startup which develops products that reduce radiation exposure from fluoroscopically guided procedures, completed its latest funding round.

The startup, located near Atlanta, Ga, raised $15 million in Series B funding from a single source, Questa Capital. It will be used for fueling the commercial launch of the ControlRad Trace system.

Trace is one of ControlRad’s products designed to improve medical safety by reducing radiation exposure without compromising image quality or workflows. They include an integrated set of proprietary components, which help the X-Ray beam to deliver optimal image quality in the needed region while maintaining appropriate resolution in the area medical pros need to treat. The company says it’s products reduces patient and medical staff exposure to radiation up to 89%.

In other news involving ControlRad, the company announced it added Ryan Drant and Tim Patrick to its board of directors. Both, according to the company, are medical device industry veterans.